Anand Mehra's Trading History
| ACRSAclaris Therapeutics | Jun 08, 2026 | Director | Uninformative Buy | 50.49K | $2.88M | |
| ONCESpark Therapeutics | Dec 17, 2019 | ― | Uninformative Sell | 59.71M | $0.00 | |
| MRNSMarinus | Oct 24, 2016 | ― | Informative Sell | 1.04M | $15.40K | |
| AERIAerie Pharma | Apr 16, 2015 | ― | Informative Sell | 14.29M | $7.16M | |
| MRUSMerus | ― | ― | ― | ― |
You May Also Like
Anand Mehra insider profile FAQ
What is the percentage of profitable transactions made by Anand Mehra?
The percentage of profitable transactions made by Anand Mehra is 63%.
What is the average return per transaction made by Anand Mehra?
The average return per transaction made by Anand Mehra is -7.40%.
What stocks does Anand Mehra hold?
Anand Mehra holds: ACRS, ONCE, MRUS, AERI, MRNS stocks.
What was Anand Mehra’s latest transaction?
Anand Mehra’s latest transaction was an Uninformative Buy of $50.49K.
What was Anand Mehra's most profitable transaction?
Anand Mehra’s most profitable transaction was an Informative Buy of MRNS stock on August 6, 2014. The return on the trade was 128.90%.
What is Anand Mehra's role in Aclaris Therapeutics?
Anand Mehra's role in Aclaris Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.